Tian, Y., Zhou, C., Yan, Q., Li, Z., Chen, D., Feng, B., & Song, J. Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production. Taylor & Francis Group.
Chicago Style (17th ed.) CitationTian, Yan, Chenxia Zhou, Qun Yan, Ziyi Li, Da Chen, Bo Feng, and Jun Song. Dapagliflozin Improves Diabetic Kidney Disease by Inhibiting Ferroptosis Through β-hydroxybutyrate Production. Taylor & Francis Group.
MLA (9th ed.) CitationTian, Yan, et al. Dapagliflozin Improves Diabetic Kidney Disease by Inhibiting Ferroptosis Through β-hydroxybutyrate Production. Taylor & Francis Group.
Warning: These citations may not always be 100% accurate.